Skip to content


Alt Text Required



Ethics Advisory Board

Since 2008, Illumina appointed an Ethics Advisory Board (EAB) to ensure Illumina is practicing fair and ethical values. The EAB meets as necessary, but at least twice a year, to advise and provide recommendations regarding ethical issues involving Illumina’s existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethics issues, policies, and regulations that are relevant to the genomic industry.